Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1893 1
1952 1
1955 1
1956 1
1962 2
1963 1
1964 1
1965 2
1966 2
1967 3
1968 1
1969 2
1970 2
1971 5
1972 3
1973 9
1974 5
1975 7
1976 5
1977 9
1978 10
1979 11
1980 2
1981 7
1982 4
1983 10
1984 9
1985 17
1986 12
1987 13
1988 9
1989 4
1990 9
1991 9
1992 10
1993 9
1994 9
1995 6
1996 12
1997 2
1998 6
1999 5
2000 10
2001 12
2002 12
2003 11
2004 3
2005 8
2006 13
2007 10
2008 9
2009 7
2010 9
2011 7
2012 9
2013 13
2014 16
2015 10
2016 6
2017 6
2018 5
2019 8
2020 11
2021 20
2022 9
2023 8
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain.
Kreiner DS, Matz P, Bono CM, Cho CH, Easa JE, Ghiselli G, Ghogawala Z, Reitman CA, Resnick DK, Watters WC 3rd, Annaswamy TM, Baisden J, Bartynski WS, Bess S, Brewer RP, Cassidy RC, Cheng DS, Christie SD, Chutkan NB, Cohen BA, Dagenais S, Enix DE, Dougherty P, Golish SR, Gulur P, Hwang SW, Kilincer C, King JA, Lipson AC, Lisi AJ, Meagher RJ, O'Toole JE, Park P, Pekmezci M, Perry DR, Prasad R, Provenzano DA, Radcliff KE, Rahmathulla G, Reinsel TE, Rich RL Jr, Robbins DS, Rosolowski KA, Sembrano JN, Sharma AK, Stout AA, Taleghani CK, Tauzell RA, Trammell T, Vorobeychik Y, Yahiro AM. Kreiner DS, et al. Among authors: rich rl jr. Spine J. 2020 Jul;20(7):998-1024. doi: 10.1016/j.spinee.2020.04.006. Epub 2020 Apr 22. Spine J. 2020. PMID: 32333996 Review.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Haller JA, et al. Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24. Ophthalmology. 2010. PMID: 20417567 Clinical Trial.
Symposium on "parental education" at the ICCH17.
Ingemann C, Kvernmo S, Møller H, Moffitt PM, Tagalik S, Kuhn RL, Nilsen SE, Rich R, Larsen CVL. Ingemann C, et al. Among authors: rich r. Int J Circumpolar Health. 2019 Dec;78(1):1604062. doi: 10.1080/22423982.2019.1604062. Int J Circumpolar Health. 2019. PMID: 31008692 Free PMC article. Review.
Uncensored exchange of scientific results.
Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby T, Kaplan S, Kennedy D, Krug J, Levinson RE, Marcus E, Metzger H, Morse SS, O'Brien A, Onderdonk A, Poste G, Renault B, Rich R, Rosengard A, Salzberg S, Scanlan M, Shenk T, Tabor H, Varmus H, Wimmer E, Yamamoto K; Journal Editors and Authors Group. Atlas R, et al. Among authors: rich r. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1464. doi: 10.1073/pnas.0630491100. Epub 2003 Feb 15. Proc Natl Acad Sci U S A. 2003. PMID: 12590129 Free PMC article. No abstract available.
Statement on scientific publication and security.
Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby T, Kaplan S, Kennedy D, Krug J, Levinson R, Marcus E, Metzger H, Morse SS, O'Brien A, Onderdonk A, Poste G, Renault B, Rich R, Rosengard A, Salzberg S, Scanlan M, Shenk T, Tabor H, Varmus H, Wimmer E, Yamamoto K; Journal Editors and Authors Group. Atlas R, et al. Among authors: rich r. Science. 2003 Feb 21;299(5610):1149. doi: 10.1126/science.299.5610.1149. Science. 2003. PMID: 12595658 No abstract available.
Statement on the consideration of biodefence and biosecurity.
Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby T, Kaplan S, Kennedy D, Krug J, Levinson R, Marcus E, Metzger H, Morse SS, O'Brien A, Onderdonk A, Poste G, Renault B, Rich R, Rosengard A, Salzberg S, Scanlan M, Shenk T, Tabor H, Varmus H, Wimmer E, Yamamoto K; Journal Editors and Authors Group. Atlas R, et al. Among authors: rich r. Nature. 2003 Feb 20;421(6925):771. doi: 10.1038/nature01479. Epub 2003 Feb 15. Nature. 2003. PMID: 12594463 No abstract available.
473 results